Combinations of meso-(4-carboxyphenyl) and meso-(4- hydroxyphenyl) porphyrins as anti-HIV-1 agents

Author:

Sharma Debdulal1,Singh Aradhana2,Safi Sanaullah2,Gaur Ritu2,Sengupta Devashish1

Affiliation:

1. Assam University

2. South Asian University

Abstract

Abstract

A series of 4-carboxyphenyl/4-hydroxyphenyl meso-substituted porphyrins were synthesized, purified, and characterized. The compounds exhibited anti-HIV-1 activities, in vitro, under both non-photodynamic (PDT) and photodynamic (PDT) conditions. Specifically, the porphyrins inhibited HIV-1 virus entry, with c-PB2(OH)2 and PB(OH)3 showing significant anti-HIV-1 activity. All of the porphyrins inhibited HIV-1 subtype B and C virus entry under PDT conditions. Our study demonstrated that the compounds bearing combinations of 4-carboxyphenyl/4-hydroxyphenyl moieties were not toxic even at higher concentrations, as compared to the reference porphyrins 5,10,15,20-tetra-(4-carboxyphenyl)porphyrin (TCPP) and 5,10,15,20-tetra-(4-hydroxyphenyl)porphyrin (THPP), under PDT conditions. This study highlighted the promising potential of the target compounds as HIV entry inhibitors in both non-PDT and PDT settings.

Publisher

Research Square Platform LLC

Reference65 articles.

1. Dynamics of viral disease outbreaks: A hundred years (1918/19–2019/20) in retrospect‐Loses, lessons and emerging issues;Nii-Trebi NI;Rev. Med. Virol.,2023

2. Cervical cancer prevention and control in women living with human immunodeficiency virus;Castle PE;CA: Cancer J. Clin,2021

3. HIV infection;Bekker L-G;Nat. Rev. Dis. Primers,2023

4. Two cationic meso-thiophenium porphyrins and their zinc-complexes as anti-HIV-1 and antibacterial agents under non-photodynamic therapy (PDT) conditions;Sengupta D;Bioorg. Med. Chem. Lett.,2022

5. Dual activity of amphiphilic Zn (II) nitroporphyrin derivatives as HIV-1 entry inhibitors and in cancer photodynamic therapy;Sengupta D;Eur. J. Med. Chem.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3